Pharsight

Drugs that contain Plazomicin Sulfate

1. Zemdri patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9688711 CIPLA USA Antibacterial aminoglycoside analogs
Nov, 2028

(4 years from now)

US8383596 CIPLA USA Antibacterial aminoglycoside analogs
Jun, 2031

(7 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9266919 CIPLA USA Antibacterial aminoglycoside analogs
Nov, 2028

(4 years from now)

US8822424 CIPLA USA Antibacterial aminoglycoside analogs
Nov, 2028

(4 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Jun 25, 2023
Generating Antibiotic Incentives Now (GAIN) Jun 25, 2028

NCE-1 date: 2027-06-26

Market Authorisation Date: 25 June, 2018

Treatment: Method of using plazomicin to treat bacterial infections

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

ZEMDRI family patents

Family Patents